Umb Bank, N.A. Blueprint Medicines Corp Transaction History
Umb Bank, N.A.
- $6.22 Billion
- Q4 2024
A detailed history of Umb Bank, N.A. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Umb Bank, N.A. holds 127 shares of BPMC stock, worth $14,484. This represents 0.0% of its overall portfolio holdings.
Number of Shares
127
Previous 143
11.19%
Holding current value
$14,484
Previous $13,000
15.38%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding BPMC
# of Institutions
353Shares Held
60.7MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$762 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$758 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$614 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$452 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$315 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.81B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...